Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies

Laura Boekel, Eileen W. Stalman, the T2B! Immunity against SARS-CoV-2 study group, Luuk Wieske, Femke Hooijberg, Koos P.J. van Dam, Yaëlle R. Besten, Laura Y.L. Kummer, Maurice Steenhuis, Zoé L.E. van Kempen, Joep Killestein, Adriaan G. Volkers, Sander W. Tas, Anneke J. van der Kooi, Joost Raaphorst, Mark Löwenberg, R. Bart Takkenberg, Geert R.A.M. D'Haens, Phyllis I. Spuls, Marcel W. BekkenkAnnelie H. Musters, Nicoline F. Post, Angela L. Bosma, Marc L. Hilhorst, Yosta Vegting, Frederike J. Bemelman, Alexandre E. Voskuyl, Bo Broens, Agner Parra Sanchez, Cécile A.C.M. van Els, Jelle de Wit, Abraham Rutgers, Karina de Leeuw, Barbara Horváth, Jan J.G.M. Verschuuren, Annabel M. Ruiter, Lotte van Ouwerkerk, Diane van der Woude, Cornelia F. Allaart, Y. K.Onno Teng, Pieter van Paassen, Matthias H. Busch, Papay B.P. Jallah, Esther Brusse, Pieter A. van Doorn, Adája E. Baars, Dirk Jan Hijnen, Corine R.G. Schreurs, W. Ludo van der Pol, Carolien van de Sandt, Olvi Cristianawati, Gertjan Wolbink, Filip Eftimov

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies'. Together they form a unique fingerprint.

Immunology and Microbiology